Shao‐Chen Yang
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 6
- Peptidase Inhibition and Analysis 3
-
- Immune cells in cancer 4
- Phagocytosis and Immune Regulation 2
- Galectins and Cancer Biology 1
- Co-authors
- Zhi‐Jun Sun (12 shared papers)Qi‐Chao Yang (10 shared papers)Zhigang Xu (6 shared papers)Tian Zhang (4 shared papers)Leilei Yang (5 shared papers)Xianbin Ma (5 shared papers)Mengyun Liang (3 shared papers)Yao Xiao (1 shared paper)
In The Last Decade
Shao‐Chen Yang
12 papers receiving 662 citations
Shao‐Chen Yang's Hit Papers
Peers
Comparison fields: 5 of 59
- Immunology 202
- Biomaterials 119
- Biomedical Engineering 323
- Oncology 139
- Molecular Biology 327
Countries citing papers authored by Shao‐Chen Yang
This map shows the geographic impact of Shao‐Chen Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shao‐Chen Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shao‐Chen Yang more than expected).
Fields of papers citing papers by Shao‐Chen Yang
This network shows the impact of papers produced by Shao‐Chen Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shao‐Chen Yang. The network helps show where Shao‐Chen Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Shao‐Chen Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Microenvironment‐Responsive Prodrug‐Induced Pyroptosis Boosts Cancer Immunotherapy Hit paper breakdown → | 2021 | 277 |
| 2 | 2021 | 103 | |
| 3 | 2020 | 85 | |
| 4 | 2021 | 50 | |
| 5 | 2020 | 37 | |
| 6 | 2022 | 26 | |
| 7 | 2022 | 26 | |
| 8 | 2022 | 24 | |
| 9 | 2023 | 19 | |
| 10 | 2023 | 15 | |
| 11 | 2020 | 2 | |
| 12 | 2019 | 1 | |
| 13 | 2025 | 0 |
About Shao‐Chen Yang
Shao‐Chen Yang is a scholar working on Oncology, Immunology, Biomedical Engineering, Molecular Biology and Management Information Systems, having authored 13 papers that have together received 665 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Nanoplatforms for cancer theranostics (5 papers), Immune cells in cancer (4 papers), Peptidase Inhibition and Analysis (3 papers), Phagocytosis and Immune Regulation (2 papers), Epigenetics and DNA Methylation (1 paper), Galectins and Cancer Biology (1 paper) and Mycobacterium research and diagnosis (1 paper). The work is most often cited by research in Immunology (202 citations), Biomaterials (119 citations), Biomedical Engineering (323 citations), Oncology (139 citations) and Molecular Biology (327 citations). Shao‐Chen Yang has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Zhi‐Jun Sun, Qi‐Chao Yang, Zhigang Xu, Tian Zhang, Leilei Yang, Xianbin Ma, Mengyun Liang, Yao Xiao, Yao Xiao and Shuo Wang. Their work appears in journals such as Acta Pharmaceutica Sinica B, Advanced Science, Chemical Communications, International Immunopharmacology and Oral Surgery Oral Medicine Oral Pathology and Oral Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.